Startsida
Hjälp
Sök i LIBRIS databas

     

 

Sökning: onr:mxsgm4gskrtqrhtb > Notch signalling in...

Notch signalling in carcinogenesis With special emphasis on T-cell lymphoma and colorectal cancer / Jonas Ungerbäck.

Ungerbäck, Jonas, 1982- (författare)
Söderkvist, Peter (preses)
Hermanson, Ola (opponent)
Linköpings universitet Institutionen för klinisk och experimentell medicin (utgivare)
Linköpings universitet Hälsouniversitetet (utgivare)
Publicerad: Linköping : Linköping University Electronic Press, 2009
Engelska 1 onlineresurs (52 sidor)
Serie: Linköping Studies in Health Sciences. Thesis, 1100-6013 1100-6013
Läs hela texten (Sammanfattning och ramberättelse från Linköping University Electronic Press)
Läs hela texten
  • E-bokAvhandling(Lic.-avh. (sammanfattning) Linköping : Linköpings universitet, 2009)
Sammanfattning Ämnesord
Stäng  
  • The Notch signalling pathway is an evolutionary conserved pathway, named after the Notch receptors, Notch1-4 in mammals, which upon cell-cell contact and ligand binding releases the intracellular domain (NICD). NICD translocates into the nucleus where it binds the transcriptional repressor RBP-Jk, which together with co-activators belonging to the Mastermind-like family of proteins form a transcriptional activation complex. This complex activates genes controlling cell fate decision, embryonic development, proliferation, differentiation, adult homeostasis and stem cell maintenance. On the other hand, disrupted Notch signalling may result in pathological conditions like cancer, although the mechanisms behind the disruption are often complex and in many cases largely unknown.??Notch1 drives the lymphocyte differentiation towards a T-cell fate and activating mutations in the gene have been suggested to be involved in T-cell lymphoma. In paper I, genetic alterations in Notch1 and the Notch1 regulating gene CDC4 were investigated in tumours from murine T-cell lymphoma induced with phenolphthalein, 1,3-butadiene or 2’,3’-dideoxycytidine. We identified activating Notch1 mutations in 39% of the lymphomas, suggesting that Notch1 is an important target gene for mutations in chemically induced lymphomas.??While it is known that constitutively activated Notch signalling has a clear oncogenic function in several solid malignancies as well, the molecular mechanisms are less known in this context. Unpublished data of our lab, together with other recent studies, suggest that mutations of Notch and Notch-related genes per se are uncommon in solid malignancies including colorectal cancer, while a growing body of evidence indicates that aberrant Wnt/b-catenin signalling may result in pro-tumoural Notch activation in these contexts. In paper II, we therefore investigated potential transcriptional interactions between the Notch and Wnt signalling pathways in colorectal cancer cell lines. The proximal Notch and Wnt pathway gene promoters were bioinformatically identified and screened for putative TCF/LEF1 and RBP-Jk sites. In canonical Wnt signalling, Apc negatively regulates b-catenin leading to repression of TCF/LEF1 target genes. Upon repression of the Wnt pathway we observed that several genes in the Notch pathway, including Notch2, were transcriptionally downregulated. We also confirmed binding of Lef1 to Notch2 as well as other Notch pathway gene promoters and luciferase assays showed an increased activity for at least one LEF1/TCF-site in the Notch2 promoter upon co-transfection of HT29 or HCT116 cells with mutated b-catenin. HT29 cell lines were also treated with the g-secretase inhibitor DAPT, leading to inactivation of the Notch pathway by preventing release of NICD. However, results showed no effects on Apc, b-catenin or their target cyclin D1. Taken together, these results indicate that the Wnt pathway may function as a regulator of the Notch pathway through the TCF/LEF1 target gene program in colon cancer cell lines.??In summary, Notch pathway deregulation is of importance in both murine T-cell lymphoma and human colorectal cancer, although the mechanisms differ. The current results give new insights in Notch pathway alterations as well as the signalling networks in which the Notch pathway interacts, and thus increase the understanding of Notch’s involvement in malignant diseases. 

Ämnesord

Colorectal neoplasms  (MeSH)
Disease models, animal  (MeSH)
Lymphoma  -- chemically induced (MeSH)
Mutation  -- genetics (MeSH)
Receptor, Notch1  -- genetics (MeSH)
Receptor, Notch2  -- genetics (MeSH)
Medical and Health Sciences  (hsv)
Basic Medicine  (hsv)
Cell and Molecular Biology  (hsv)
Medicin och hälsovetenskap  (hsv)
Medicinska och farmaceutiska grundvetenskaper  (hsv)
Cell- och molekylärbiologi  (hsv)
MEDICINE  (svep)
Morphology, cell biology, pathology  (svep)
Cell biology  (svep)
Medical cell biology  (svep)
MEDICIN  (svep)
Morfologi, cellbiologi, patologi  (svep)
Cellbiologi  (svep)
Medicinsk cellbiologi  (svep)

Genre

government publication  (marcgt)

Indexterm och SAB-rubrik

Notch signalling
T-cell lymphoma
colorectal cancer
Wnt signalling
transcription
Vep Onkologi (läran om tumörer)

Klassifikation

616.994 (DDC)
Vep (kssb/8)
Inställningar Hjälp

Titeln finns på 1 bibliotek. 

Bibliotek i östra Sverige (1)

Ange som favorit
Om LIBRIS
Sekretess
Hjälp
Fel i posten?
Kontakt
Teknik och format
Sök utifrån
Sökrutor
Plug-ins
Bookmarklet
Anpassa
Textstorlek
Kontrast
Vyer
LIBRIS söktjänster
SwePub
Uppsök

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy